California Public Employees Retirement System Global Blood Therapeutics, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 09, 2022	BUY	$32.4 - $68.18 $5.13 Million - $10.8 Million	158,222 New	158,222 $10.8 Million
Q2 2021 Aug 13, 2021	SELL	$32.46 - $43.42 $3.92 Million - $5.24 Million	-120,623 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$38.94 - $50.85 $696,792 - $909,909	-17,894 Reduced 12.92%	120,623 $4.92 Million
Q4 2020 Feb 02, 2021	BUY	$37.65 - $63.77 $184,673 - $312,791	4,905 Added 3.67%	138,517 $6 Million
Q3 2020 Nov 05, 2020	BUY	$52.76 - $74.49 $153,320 - $216,467	2,906 Added 2.22%	133,612 $7.37 Million
Q2 2020 Aug 12, 2020	BUY	$48.73 - $81.82 $80,599 - $135,330	1,654 Added 1.28%	130,706 $8.25 Million
Q1 2020 May 12, 2020	SELL	$41.72 - $87.2 $1.5 Million - $3.14 Million	-35,980 Reduced 21.8%	129,052 $6.59 Million
Q4 2019 Jan 27, 2020	BUY	$45.7 - $81.86 $2.32 Million - $4.15 Million	50,721 Added 44.37%	165,032 $13.1 Million
Q3 2019 Oct 31, 2019	BUY	$45.35 - $57.91 $2.58 Million - $3.29 Million	56,787 Added 98.72%	114,311 $5.55 Million
Q2 2019 Aug 15, 2019	BUY	$52.6 - $63.29 $507,958 - $611,191	9,657 Added 20.17%	57,524 $3.03 Million
Q1 2019 May 03, 2019	SELL	$39.99 - $53.48 $27,993 - $37,436	-700 Reduced 1.44%	47,867 $2.53 Million
Q4 2018 Feb 08, 2019	SELL	$31.54 - $46.67 $123,006 - $182,013	-3,900 Reduced 7.43%	48,567 $1.99 Million
Q3 2018 Nov 13, 2018	SELL	$38.0 - $51.1 $196,764 - $264,595	-5,178 Reduced 8.98%	52,467 $1.99 Million
Q2 2018 Aug 15, 2018	BUY	$38.7 - $50.15 $1.93 Million - $2.5 Million	49,927 Added 646.89%	57,645 $2.61 Million
Q1 2018 May 11, 2018	SELL	$39.6 - $65.9 $100,742 - $167,649	-2,544 Reduced 24.79%	7,718 $373,000
Q4 2017 Feb 06, 2018	BUY	$29.7 - $45.7 $304,781 - $468,973	10,262	10,262 $404,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account